Michelle Dawson posts

Post published on Twitter/X on 3 Jun 2013 00:10

Back to posts Previous post Next post
Twitter/X Clinical trial clinicaltrials.gov External link integrated into the post
Open original post

Information about the link integrated into the post

Clinical trial

Seaside Therapeutics, Inc. (2011). A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome. ClinicalTrials.gov. Seaside Therapeutics, Inc..

More information

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

Seaside Therapeutics, Inc. (2011). A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome. ClinicalTrials.gov. Seaside Therapeutics, Inc..

Publication date
2011
Identifier
NCT01325740
Authors
Seaside Therapeutics, Inc.
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
Seaside Therapeutics, Inc.
Metadata source
clinicaltrials.gov

Abstract

The study will consist of a Screening period (up to 14 days), a Treatment period, and a Follow-Up period. Sixteen subjects will be enrolled into two sequential dose cohorts - 10 or 30 mg (or matching placebo) across four study centers.

Open source